BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38394744)

  • 21. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.
    Veraar C; Kliman J; Benazzo A; Oberndorfer F; Laggner M; Hacker P; Raunegger T; Janik S; Jaksch P; Klepetko W; Ankersmit HJ; Moser B
    Sci Rep; 2021 Mar; 11(1):6799. PubMed ID: 33762606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
    Verleden GM; Godinas L; Vos R; Verleden SE
    Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive methods for detection of chronic lung allograft dysfunction in lung transplantation.
    Tian D; Huang H; Wen HY
    Transplant Rev (Orlando); 2020 Jul; 34(3):100547. PubMed ID: 32498976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction.
    Saito T; Liu M; Binnie M; Sato M; Hwang D; Azad S; Machuca TN; Zamel R; Waddell TK; Cypel M; Keshavjee S
    Am J Transplant; 2014 Jun; 14(6):1425-32. PubMed ID: 24787265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
    Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
    Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation.
    Vanstapel A; Verleden SE; Verbeken EK; Braubach P; Goos T; De Sadeleer L; Kaes J; Vanaudenaerde BM; Jonigk D; Ackermann M; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Vos R; Verleden GM; Weynand B; On Behalf Of The Leuven Lung Transplant Group
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative computed tomography assessment of bronchiolitis obliterans syndrome after lung transplantation.
    Gazourian L; Ash S; Meserve EEK; Diaz A; Estepar RSJ; El-Chemaly SY; Rosas IO; Divo M; Fuhlbrigge AL; Camp PC; Ho VT; Bhatt AS; Goldberg HJ; Sholl LM; Washko GR
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28244139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lung allograft dysfunction subtype analysis by computed tomography volumetry.
    Peräkylä LH; Raivio PM; Kesävuori RI; Piilonen AK; Stark CK; Halme MK; Nykänen AI
    Clin Transplant; 2022 Jan; 36(1):e14507. PubMed ID: 34634164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.